Multicenter Assessment of Neoadjuvant Chemotherapy for Muscle-invasive Bladder CancerHomayoun Zargar, Peter C. Black, Niels-Erik Jacobsen et al.|European Urology|2014Cited by 297
The prognostic value of the neutrophil-to-lymphocyte ratio in patients with muscle-invasive bladder cancer treated with neoadjuvant chemotherapy and radical cystectomyAnna J. Black, Peter C. Black, Homayoun Zargar et al.|Urologic Oncology Seminars and Original Investigations|2019Cited by 44
Nomogram Predicting Bladder Cancer–specific Mortality After Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-invasive Bladder Cancer: Results of an International ConsortiumMaria Carmen Mir, Peter C. Black, Michele Marchioni et al.|European Urology Focus|2020Cited by 34
Podium Session 1: Prostate Cancer June 26, 2016 1050–1150D. Robert Siemens, Ronald Kodama, Henry Klotz et al.|Europe PMC (PubMed Central)|2016Cited by 0